NO20075393L - Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse - Google Patents

Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse

Info

Publication number
NO20075393L
NO20075393L NO20075393A NO20075393A NO20075393L NO 20075393 L NO20075393 L NO 20075393L NO 20075393 A NO20075393 A NO 20075393A NO 20075393 A NO20075393 A NO 20075393A NO 20075393 L NO20075393 L NO 20075393L
Authority
NO
Norway
Prior art keywords
acarbose
treatment
chronic constipation
designs
based methods
Prior art date
Application number
NO20075393A
Other languages
English (en)
Norwegian (no)
Inventor
John Devane
Original Assignee
Agi Therapeutics Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agi Therapeutics Res Ltd filed Critical Agi Therapeutics Res Ltd
Publication of NO20075393L publication Critical patent/NO20075393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20075393A 2005-04-12 2007-10-23 Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse NO20075393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67026505P 2005-04-12 2005-04-12
PCT/IB2006/001842 WO2006134492A2 (fr) 2005-04-12 2006-03-31 Procedes et formulations a base d'acarbose pour traiter la constipation chronique

Publications (1)

Publication Number Publication Date
NO20075393L true NO20075393L (no) 2007-10-23

Family

ID=37198819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075393A NO20075393L (no) 2005-04-12 2007-10-23 Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse

Country Status (9)

Country Link
US (1) US20060229261A1 (fr)
EP (1) EP1871393A2 (fr)
JP (1) JP2008535905A (fr)
AU (1) AU2006257281A1 (fr)
CA (1) CA2599063A1 (fr)
IL (1) IL185602A0 (fr)
MX (1) MX2007010886A (fr)
NO (1) NO20075393L (fr)
WO (1) WO2006134492A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2622558A1 (fr) * 2005-09-14 2007-03-22 Elixir Pharmaceuticals, Inc. Therapie combinatoire pour une digestion controlee des glucides
US20080069906A1 (en) * 2006-09-18 2008-03-20 Thompson Ronald J Method and composition of a carminative herb or natural supplement to decrease the adverse effects of orlistat, and oral lipase inhibitor
US7662373B2 (en) * 2006-09-18 2010-02-16 Thompson Ronald J Method and composition of a medicament to decrease the adverse events of Olistat, an oral lipase inhibitor
WO2008070308A2 (fr) * 2006-10-24 2008-06-12 Thompson Md Ronald J Procédé et composition d'une herbe carminative ou d'un complément naturel permettant de diminuer les effets néfastes de l'orlistat, un inhibiteur de lipase oral, et un procédé avec des formulations permettant simultanément de réduire un risque de fracture et d'assurer
DE102010012183A1 (de) * 2010-03-19 2011-09-22 Fresenius Medical Care Deutschland Gmbh Veresterte Polysaccharid-Osmotika
MY179724A (en) * 2010-04-27 2020-11-11 Bayer Ip Gmbh Orally disintegrating tablet containing acarbose
WO2014032108A1 (fr) * 2012-08-29 2014-03-06 Borody Thomas J Compositions de laxatif et méthodes de traitement de la constipation et des maladies et troubles gastro-intestinaux associés
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
MY195038A (en) 2014-12-17 2023-01-04 Empros Pharma Ab A Modified Release Composition of Orlistat and Acarbose for the Treatment of Obesity and Related Metabolic Disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US6849609B2 (en) * 2001-04-10 2005-02-01 James U. Morrison Method and composition for controlled release acarbose formulations
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form

Also Published As

Publication number Publication date
US20060229261A1 (en) 2006-10-12
WO2006134492A3 (fr) 2007-03-08
CA2599063A1 (fr) 2006-12-21
MX2007010886A (es) 2008-04-17
AU2006257281A1 (en) 2006-12-21
JP2008535905A (ja) 2008-09-04
WO2006134492A2 (fr) 2006-12-21
IL185602A0 (en) 2008-08-07
EP1871393A2 (fr) 2008-01-02

Similar Documents

Publication Publication Date Title
NO20075393L (no) Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse
NO20075344L (no) Metforminbaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse
DK1412368T3 (da) Sukkerderivater af hydromorfon, dihydromorfin, dihydroisomorfin, sammensætninger deraf og anvendelser til behandling eller forebyggelse af smerter
EA201100313A1 (ru) Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
AR075423A1 (es) Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos
NO20083885L (no) Fremgangsmate for behandling av inflammatoriske sykdommer
WO2008040534A3 (fr) Formes pharmaceutiques à base de film non muco-adhésif
NO20074628L (no) Formuleringer av octreotid med kontrollert frigjoring
AR074313A1 (es) Metodo para tratar o prevenir la trombosis utilizando etexilato de dabigatran o una sal del mismo. uso. kit
ECSP17000643A (es) Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol.
HK1176318A1 (en) Injection device
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
WO2007062093A3 (fr) Polytherapie pour le traitement du cancer
NO20070597L (no) Medikamtenter for a behandle kronisk respiratorisk sykdom.
NZ592615A (en) Method for treating or preventing thrombosis using 150 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
NO20081863L (no) Forhindring og behandling av gastrointestinal og blaerelidelse assosiert med kemoterapi eller stralingsterapi ved bruk av aktiv vitamin D forbindelse
WO2008070010A3 (fr) Rétablissement après une attaque
WO2007145863A3 (fr) Formulation à libération prolongée de naltréxone
ATE413187T1 (de) Pharmazeutische zusammensetzungen mit interferon- tau
EA201270747A1 (ru) Композиции и способы для профилактики и лечения ран
NZ592613A (en) Method for treating or preventing thrombosis using >150 mg to 300 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
NO20021437L (no) Fremgangsmate til forebyggelse av colorektal kreft
DK1732551T3 (da) Perhexilin til behandling af kronisk hjertesvigt
BRPI0918593A2 (pt) composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente
WO2016122288A3 (fr) Formulation combinée comprenant un dérivé de verbénone et un agent thérapeutique pour une reperfusion pour la prévention ou le traitement de maladies cérébrovasculaires, de l'artériosclérose ou de maladies cardio-vasculaires

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application